4 ms·

> By CHRISTINA SMOLKE JULY 16, 2020 { article } > Christina Smolke is the CEO and co-founder of Antheia, a synthetic biology company based in Menlo Park, Cali

• toufka 6y ago
  Yes? But you also left off the rest of her bio: ", professor of bioengineering at Stanford University, and a member of the National Academies’ Committee on Science and Innovation Leadership for the 21st Century." She is an accomplished academic scientist who is now putting her effort into a technology where her science portends value. And she's explaining that technology here. The idea is actually a very strong idea with hints towards an even more interesting future. Bionengineering these pathways into an organism (even yourself) gets you a lot of significant benefits: - dropping the reliance on petrochemical precursors for manufacturing - a large number of biosimilar compounds for the cost of a few rounds of evolution - manufacturing is constant across many different drugs and involves 3 ingredients: water, light & sugar - manufacturing is much easier and can be transported "in house" eventually into smaller and smaller scales (think yogurt or a shot of espresso) - etc.
  • untilHellbanned 6y ago
    I didn't say anything about the strength of the idea. Her Stanford credentials are irrelevant. It's still an ad.